819.51
price down icon0.16%   -0.59
 
loading

Lilly Eli Co Aktie (LLY) Neueste Nachrichten

pulisher
11:49 AM

Eli Lilly to invest $1.2 billion in Puerto Rico as part of US manufacturing push - WTVB

11:49 AM
pulisher
11:44 AM

Eli Lilly, Walmart Announce Expansion of Direct-to Consumer Access for Tirzepatide - Drug Topics

11:44 AM
pulisher
11:40 AM

Jim Cramer on Eli Lilly Stock “Needs Some Kind of Catalyst to Get Things Going” - Yahoo! Finance UK

11:40 AM
pulisher
11:35 AM

Lilly aligns with Walmart in bid to broaden access to discounted Zepbound - BioPharma Dive

11:35 AM
pulisher
11:14 AM

Lilly, Walmart launch discount retail option for weight-loss drug Zepbound - Reuters

11:14 AM
pulisher
11:13 AM

Eli Lilly, Walmart partner to bring Zepbound to customers with direct-to-consumer pricing - WSOC TV

11:13 AM
pulisher
11:06 AM

Eli Lilly to Invest $1.2 Billion in Puerto Rico Plant Expansion - MarketScreener

11:06 AM
pulisher
11:05 AM

Eli Lilly (LLY) Pours $1.2 Billion into Puerto Rico Expansion - GuruFocus

11:05 AM
pulisher
11:01 AM

Eli Lilly to invest $1.2B in Puerto Rico plant - breakingthenews.net

11:01 AM
pulisher
10:56 AM

Walmart and Eli Lilly to Offer In-Store Pickup for Zepbound With Direct-to-Consumer Pricing - PYMNTS.com

10:56 AM
pulisher
10:55 AM

Lilly expands Zepbound direct-to-patient access through Walmart partnership - Indianapolis Business Journal

10:55 AM
pulisher
10:53 AM

Lilly Announces Partnership with Walmart Pharmacy Launching First Retail Pick-Up Option Offering Direct-To-Consumer Priced Zepbound - Pharmaceutical Commerce

10:53 AM
pulisher
10:48 AM

Eli Lilly announces over $1.2B investment in Puerto Rico faciliy - TipRanks

10:48 AM
pulisher
10:32 AM

Eli Lilly invests $1.2 billion to expand Puerto Rico manufacturing site - StreetInsider

10:32 AM
pulisher
10:31 AM

Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States - MarketScreener

10:31 AM
pulisher
10:01 AM

What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree? - The Globe and Mail

10:01 AM
pulisher
09:09 AM

Eli Lilly (LLY) and Walmart Partner to Expand Access to Zepbound - GuruFocus

09:09 AM
pulisher
08:30 AM

Eli Lilly, Walmart bring retail pick-up option with DTC pricing for Zepbound (WMT:NYSE) - Seeking Alpha

08:30 AM
pulisher
07:30 AM

Eli Lilly strikes deal with Walmart to distribute cash-pay Zepbound vials - Sherwood News

07:30 AM
pulisher
07:20 AM

Lilly, Walmart launch first retail pick-up option for weight-loss drug - Yahoo! Finance Canada

07:20 AM
pulisher
05:45 AM

Eli Lilly Partners With Walmart To Expand Access To Popular Weight-loss Drug - Stocktwits

05:45 AM
pulisher
05:00 AM

Why Eli Lilly and Company stock is a strong buy callJuly 2025 Spike Watch & Accurate Trade Setup Notifications - Fundação Cultural do Pará

05:00 AM
pulisher
05:00 AM

Top News Today: Lilly-NVIDIA AI Drug Discovery Deal, Sequoia’s $950M Fund Launch - Analytics Insight

05:00 AM
pulisher
03:40 AM

Eli Lilly and Nvidia team up to build an AI supercomputer dedicated to drug discovery - MarketScreener

03:40 AM
pulisher
02:38 AM

Eli Lilly partners with Nvidia to build AI supercomputer for drug discovery | Mint - Mint

02:38 AM
pulisher
01:56 AM

Opportunities Amid Stock Price Correction? Decoding Eli Lilly’s Moat and Growth Potential - NAI500

01:56 AM
pulisher
12:42 PM

Lilly partners with Nvidia on AI supercomputer to speed up drug development - The Hindu

12:42 PM
pulisher
Oct 28, 2025

Eli Lilly (LLY) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

Lilly, Nvidia team up to build pharma’s ‘most powerful’ supercomputer - Indianapolis Business Journal

Oct 28, 2025
pulisher
Oct 28, 2025

How Omvoh’s FDA Approval at Eli Lilly (LLY) Has Changed Its Investment Story - Yahoo Finance

Oct 28, 2025
pulisher
Oct 28, 2025

1 Undervalued Growth Stock Down 8% to Buy Before 2026 - The Motley Fool

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly and Company unveils Milan-Cortina athlete roster - Sports Business Journal

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly (LLY) Partners with Nvidia for AI-Driven Drug Discover - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Lilly says it’s building pharma’s most powerful AI supercomputer with Nvidia - R&D World

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly, J&J working with Nvidia to boost AI capabilities (LLY:NYSE) - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly and Company Partners with Nvidia to Build the Most Powerful Ai Supercomputer, Supercharging Medicine Discovery and Delivery for Patients - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly, NVIDIA team up to build pharma’s biggest AI supercomputer - statnews.com

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly And Nvidia Build A Supercomputer For Drug Discovery - Finimize

Oct 28, 2025
pulisher
Oct 28, 2025

NVIDIA (NVDA.US) partners with Eli Lilly and Co (LLY.US) to develop an AI-powered supercomputer for pharmaceutical applications. - 富途牛牛

Oct 28, 2025
pulisher
Oct 28, 2025

Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patients - Investing News Network

Oct 28, 2025
pulisher
Oct 28, 2025

Lilly keeps up legal fight against GLP-1 compounders - Endpoints News

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly partners with Nvidia to build pharma’s most powerful AI supercomputer - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly and Nvidia team up to build 'most powerful' supercomputer in pharma - Fierce Biotech

Oct 28, 2025
pulisher
Oct 28, 2025

Nvidia, Eli Lilly to build supercomputer for AI drug factory - breakingthenews.net

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly is stockpiling its weight loss pill, plus Nvidia reveals (many) new partners - CNBC

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development - CNBC

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly, Nvidia say they'll build pharma's largest supercomputer - Endpoints News

Oct 28, 2025
pulisher
Oct 28, 2025

More than a third of Lilly's new Zepbound prescriptions are coming from DTC program - Endpoints News

Oct 28, 2025
pulisher
Oct 28, 2025

Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earnings - CNBC

Oct 28, 2025
pulisher
Oct 28, 2025

Why Eli Lilly and Company stock remains on buy listsQuarterly Risk Review & Growth Focused Investment Plans - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly (LLY) Prepares for Major Launch of New Weight-Loss Pil - GuruFocus

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly readies billions of weight-loss pills ahead of U.S. approval (LLY:NYSE) - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

FDA OKs Once-Monthly Omvoh Injection Could Be a Game Changer for Eli Lilly (LLY) - simplywall.st

Oct 28, 2025
pulisher
Oct 28, 2025

Lilly Makes Billions of Weight-Loss Pills Before US Approval - Bloomberg.com

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly Manufactures Billions of New Weight-Loss Pill Ahead of US Approval - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly teams up with basketball legend Shaquille O'Neal to take sleep apnea awareness campaign to new heights - Fierce Pharma

Oct 28, 2025
pulisher
Oct 28, 2025

With Adverum, Eli Lilly Made A Small Bet That Could Pay Off Big (NYSE:LLY) - Seeking Alpha

Oct 28, 2025
pulisher
Oct 28, 2025

Eli Lilly Taps Eyecare Market With Definitive Agreement to Acquire Adverum Biotechnologies - VisionMonday.com

Oct 28, 2025
pulisher
Oct 27, 2025

Will Eli Lilly and Company stock maintain momentum in 2025Market Weekly Review & Expert Approved Momentum Ideas - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Eli Lilly’s New Study on Pirtobrutinib: A Long-Term Safety Evaluation - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Seeking Clues to Lilly (LLY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics - sharewise.com

Oct 27, 2025
pulisher
Oct 27, 2025

Eli Lilly (LLY) Gains FDA Approval for Monthly Ulcerative Colitis Treatment - GuruFocus

Oct 27, 2025
pulisher
Oct 27, 2025

Eli Lilly’s New Study on LY3537031: What Investors Need to Know - TipRanks

Oct 27, 2025
drug_manufacturers_general JNJ
$185.47
price down icon 0.77%
$225.22
price down icon 1.02%
drug_manufacturers_general NVS
$122.12
price down icon 1.03%
drug_manufacturers_general MRK
$86.29
price down icon 0.79%
drug_manufacturers_general NVO
$51.43
price down icon 1.23%
Kapitalisierung:     |  Volumen (24h):